Literature DB >> 8890046

ELISA for the detection of serum and saliva IgA against the BMRFI gene product of Epstein-Barr virus.

E C Nadala1, T M Tan, H M Wong, R C Ting.   

Abstract

The BMRF1 protein is an Epstein-Barr virus (EBV) DNA polymerase accessory protein that forms part of the early antigen diffuse (EA-D) component. An enzyme-linked immunosorbent assay (ELISA) was developed for the detection of IgA antibody to the BMRF1 protein of EBV in saliva and serum samples. The assay was shown to be specific for nasopharyngeal carcinoma (NPC) patients and, when used with saliva alone, to have a sensitivity comparable to an existing indirect immunoperoxidase assay for early antigens. The sensitivity of the assay could be significantly enhanced to 86% by the use of paired saliva and serum samples.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8890046     DOI: 10.1002/(SICI)1096-9071(199609)50:1<93::AID-JMV15>3.0.CO;2-Z

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  2 in total

1.  Tumor microenvironment contributes to Epstein-Barr virus anti-nuclear antigen-1 antibody production in nasopharyngeal carcinoma.

Authors:  Ping Ai; Zhiping Li; Yong Jiang; Changping Song; Lin Zhang; Huaizhong Hu; Tao Wang
Journal:  Oncol Lett       Date:  2017-06-22       Impact factor: 2.967

2.  Early detection of nasopharyngeal carcinoma.

Authors:  Keiji Tabuchi; Masahiro Nakayama; Bungo Nishimura; Kentaro Hayashi; Akira Hara
Journal:  Int J Otolaryngol       Date:  2011-06-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.